The Most Expensive Part of Healthcare Technology May Be the Wait

When a practice prices a new technology, it starts with the software, the implementation and the people needed to support it. One cost almost never makes it into the business case: what it costs to keep running the current process while you decide.

Healthcare technology decisions should involve security reviews, compliance, procurement and contracting. Those steps protect patients and data. But the problem you're trying to solve doesn't pause while they happen. Coordinators keep working the fax inbox by hand. The backlog keeps growing. The team still can't take on more referrals. Patients wait for a callback.

The real test of any technology isn't whether AI appears somewhere in the process. It's whether the process changes because of it. And every month spent deciding is another month of the old process.

So here's the question: Should the cost of waiting be part of the ROI calculation?

Time-to-Value Starts Before Implementation

Most technology companies measure time-to-value from the day implementation starts: how fast the system is deployed, when staff start using it, how soon results appear. That leaves out everything that happens before.

An operations leader may spot a problem months before anything is deployed. In between, IT, security, compliance, procurement, legal and the executive team all weigh in.

Those reviews are necessary. They don't make the current process any cheaper. If your team spends hundreds of hours a month on work that software can already do, three more months of evaluation is three more months of that work. If a referral backlog is holding up patient access, it stays in place until something changes.

So the clock really starts when your organization decides a problem is worth solving, not when implementation begins.

The Status Quo Has a Price

A technology business case asks whether the expected return justifies the investment. Software, implementation, staffing, projected efficiencies and financial outcomes all go into that math.

Your current process deserves the same scrutiny. Manual staff hours cost money. So does overtime. Backlogs cost money and patients. A team that's already at capacity can't support growth. And when patients get stuck in administrative steps, both care and revenue slow down.

The scale isn't small. Routine administrative work, such as verifying insurance, accounts for about $90 billion in annual U.S. healthcare spending, and the industry could save upwards of $20 billion more through automation, according to the 2024 CAQH Index, as reported by AJMC.

None of this means every decision should move faster. Sometimes more evaluation keeps you from an expensive mistake: the technology doesn't deliver enough value, the fit is wrong, or the risks outweigh the return.

But waiting isn't free. A complete business case weighs the cost of change against the cost of staying put.

Responsible Governance and Faster Evaluation Can Coexist

Healthcare organizations manage sensitive information in complex digital environments. As AI spreads, security, compliance and governance matter more, not less.

The goal is to make evaluation more efficient without making it less rigorous.

Not every assessment needs to start from scratch. Standard ways to share vendor information, security requirements, purchasing terms and governance expectations let your team focus on the risks that are specific to you.

We've seen this firsthand since Titan Intake became available through Microsoft Marketplace. Marketplaces don't replace due diligence, and they shouldn't. But they can take the repetitive parts of procurement off your team's plate.

Once the Basics Are Established, Spend More Time on Proof

As AI shows up in more healthcare products, more vendors will make the same claims about automation and efficiency. That makes operational proof matter more.

Referral management is a good example because the work is tangible. Referrals arrive by fax, portal and email. Someone reviews the clinical documents, pulls out the relevant information and routes the referral before the patient can move forward.

So measure what changes:

• Are referrals processed faster?

• Do staff spend less time on repetitive work?

• Can the same team handle more volume?

• Is the backlog shrinking?

• Are more patients reaching care?

If you want to put a dollar figure on that last one, start with what your referrals are actually worth.

Those are harder questions than whether a vendor meets baseline requirements. They're also the ones that decide whether an investment creates value. The faster you settle the basics, the more time you have for proof.

Add the Cost of Delay to the Business Case

Healthcare is being asked to innovate faster while governing technology more carefully. Those goals usually get framed as competing. They don't have to be.

Strong governance builds trust. Efficient evaluation cuts unnecessary friction. Operational evidence shows whether a technology deserves the investment.

Before your next technology review, ask:

• How many staff hours will go to work that software can already do while we decide?

• What happens to our capacity in the meantime?

• What does a growing backlog mean for patients and operations?

• Which opportunities are we passing on because the team is already at its limit?

These questions don't decide the answer for you. They make the business case complete.

Next time you calculate the cost of a technology decision, calculate both sides: what it costs to move forward, and what it costs to wait.